Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vox sanguinis

Showing results (1-10 of 7,325) with videos related to

Pageof 733
Sort By:
Vox Sanguinis|May 22, 2003
Solvent-detergent-treated plasma may be cost-effectiveG F Riedler, A R Haycox, A K Duggan, et al.
Vox Sanguinis|January 1, 1992
Seropositivity to hepatitis C virus in Saudi haemodialysis patientsM N al Nasser, M A al Mugeiren, S A Assuhaimi, et al.
Vox Sanguinis|March 1, 2003
Nanofiltration of single plasma donations: feasibility studyT Burnouf, M Radosevich, M El-Ekiaby, et al.
Vox Sanguinis|January 1, 1992
Distribution of polymorphic HLA-DR and -DQ alleles as determined by restriction fragment length polymorphism analysis in an Austrian populationG F Fischer, I Faé, W F Pickl
Vox Sanguinis|January 1, 1992
Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptorC C Silliman, G W Thurman, D R Ambruso
Vox Sanguinis|January 1, 1990
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study GroupS L Dietrich, J W Mosley, J M Lusher, et al.
Vox Sanguinis|January 1, 1990
Storage of ADSOL-preserved red cells at 2.5 and 5.5 degrees C: comparable retention of in vitro propertiesG Moroff, S Holme, T Keegan, et al.
Vox Sanguinis|January 1, 1990
Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newbornJ M Pollock, J M Bowman
Vox Sanguinis|December 24, 2010
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st centuryD M Dwyre, L P Fernando, P V Holland
Vox Sanguinis|December 24, 2010
Developing pathogen reduction technologies for RBC suspensionsS J Wagner
Pageof 733

Showing results (1-10 of 7,325) with videos related to

Sort By:
Pageof 733
Vox Sanguinis|May 22, 2003
Solvent-detergent-treated plasma may be cost-effectiveG F Riedler, A R Haycox, A K Duggan, et al.
Vox Sanguinis|January 1, 1992
Seropositivity to hepatitis C virus in Saudi haemodialysis patientsM N al Nasser, M A al Mugeiren, S A Assuhaimi, et al.
Vox Sanguinis|March 1, 2003
Nanofiltration of single plasma donations: feasibility studyT Burnouf, M Radosevich, M El-Ekiaby, et al.
Vox Sanguinis|January 1, 1992
Distribution of polymorphic HLA-DR and -DQ alleles as determined by restriction fragment length polymorphism analysis in an Austrian populationG F Fischer, I Faé, W F Pickl
Vox Sanguinis|January 1, 1992
Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptorC C Silliman, G W Thurman, D R Ambruso
Vox Sanguinis|January 1, 1990
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study GroupS L Dietrich, J W Mosley, J M Lusher, et al.
Vox Sanguinis|January 1, 1990
Storage of ADSOL-preserved red cells at 2.5 and 5.5 degrees C: comparable retention of in vitro propertiesG Moroff, S Holme, T Keegan, et al.
Vox Sanguinis|January 1, 1990
Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newbornJ M Pollock, J M Bowman
Vox Sanguinis|December 24, 2010
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st centuryD M Dwyre, L P Fernando, P V Holland
Vox Sanguinis|December 24, 2010
Developing pathogen reduction technologies for RBC suspensionsS J Wagner
Pageof 733